Form 8-K - Current report:
SEC Accession No. 0001104659-21-016324
Filing Date
2021-02-09
Accepted
2021-02-09 07:11:19
Documents
14
Period of Report
2021-02-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm215720d1_8k.htm   iXBRL 8-K 25317
2 EXHIBIT 99.1 tm215720d1_ex99-1.htm EX-99.1 259848
6 GRAPHIC tm215720d1_ex99-1img1.jpg GRAPHIC 4607
  Complete submission text file 0001104659-21-016324.txt   492599

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA incy-20210209.xsd EX-101.SCH 3181
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE incy-20210209_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE incy-20210209_pre.xml EX-101.PRE 22707
7 EXTRACTED XBRL INSTANCE DOCUMENT tm215720d1_8k_htm.xml XML 3492
Mailing Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803
Business Address 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 3024986700
INCYTE CORP (Filer) CIK: 0000879169 (see all company filings)

EIN.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12400 | Film No.: 21603923
SIC: 8731 Services-Commercial Physical & Biological Research